Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016 in Dongguan, China—a hub for medical innovation—we operate an 11,000 square meter facility with over 230 employees.
Our expertise spans remote clinical trial monitoring, wearable health data collection systems, and patient engagement platforms. We provide high-quality OEM and ODM services tailored to specific research applications, integrating cloud-based data management with intelligent monitoring functions.
Serving North America, Europe, Asia-Pacific, and the Middle East, we are committed to advancing digital clinical research. Our solutions are designed to facilitate real-time data collection and improve participant engagement throughout the clinical research process.
Digital Therapeutics (DTx) represent a paradigm shift in how we treat, manage, and prevent diseases. Unlike traditional medications or general wellness apps, DTx are evidence-based, clinically validated software used to provide medical interventions. As a leading manufacturer and supplier in China, we integrate advanced IoT hardware with sophisticated digital platforms to deliver a holistic therapeutic experience.
The global Digital Therapeutics market is projected to grow at a CAGR of over 20% in the coming decade. Regulatory bodies such as the FDA (USA), NMPA (China), and EMA (Europe) have established clear pathways for Software-as-a-Medical-Device (SaMD). This transition is driven by the need for cost-effective chronic disease management and the rise of Decentralized Clinical Trials (DCT), which allow patients to participate in studies from their homes using remote monitoring technology.
China, particularly the Dongguan medical-tech cluster, offers a unique advantage for DTx platform development. The synergy between high-speed electronic manufacturing and rapid software iteration allows us to produce Remote Safety Monitoring Systems and eCOA (electronic Clinical Outcome Assessment) tools at a scale and speed that is unmatched globally. Our facility ensures that medical-grade hardware meets strict quality control while keeping costs competitive for global procurement.
Continuous monitoring of diabetes, hypertension, and respiratory conditions through wearable health data collection, providing real-time feedback to both patient and provider.
Digital cognitive behavioral therapy (CBT) platforms for depression, anxiety, and ADHD, validated through electronic clinical outcome assessments.
Remote clinical trial monitoring devices ensure patients recovering at home are adhering to protocols and showing positive vital sign trends.
For international pharmaceutical companies and research institutions, sourcing from a top China DTx supplier means access to integrated supply chains. We offer:
Algorithms that adjust therapeutic dosages based on real-time patient biometrics.
Ultra-low latency data transmission for critical remote safety monitoring.
Improving patient engagement and adherence through immersive digital experiences.
Using population-scale data to refine clinical research protocols and drug efficacy studies.
Trial Medical
